Диссертация (1139658), страница 42
Текст из файла (страница 42)
– 2002. – Vol.44. – P. 640–649.365.Pachange, S. An ensemble classifier approach for disease diagnosis usingRandom Forest [Electronic resource] / S. Pachange, B. Joglekar, P. Kulkarni //IndiaConference(INDICON),2015AnnualIEEE.–URL:http://ieeexplore.ieee.org/document/7443826/.366.Pai, M. Systematic review: T-cell-based assays for the diagnosis of latenttuberculosis infection: an update / M. Pai, A.
Zwerling, D. Menzies // Ann.Intern. Med. – 2008. – Vol. 149, № 3. – P. 177–184.367.Pan-Hammarstrom, Q. Class switch recombination: a comparison betweenmouse and human / Q. Pan-Hammarstrom, Y. Zhao, L. Hammarstrom // Adv.Immunol. 2007. – Vol. 93. – P. 1– 61.243368.PCR-based method to differentiate the subspecies of Mycobacteriumtuberculosis complex on the basis genomic deletions / R.
C. Huard [et al.] // Clin.Microbiol. – 2003. – Vol. 41. – P. 1637-1650.369.Pereira, C. B. Interferon--Receptor deficiency in an infant with fatal bacilliCalmette-Guerin infection / C. B. Pereira, M. Palaci, O. H. Leite // Microb.Infect. – 2004. – Vol. 6. – P. 25-33.370.Persistent epigenetic differences associated with prenatal exposure tofamine in humans / B. T. Heijmans [et al.] // Proc.
Natl. Acad. Sci. – 2008. – Vol.105, № 44. – P. 17046–17049.371.Phenotypic classification of human CD4+ T cell subsets and theirdifferentiation / R. Okada [et al.] // Int. Immunol. – 2008. – Vol. 20, № 9. – P.1189-1199.372.Physiology of mycobacteria / G.
M. Cook [et al.] // Adv. Microb. Physiol. –2009. – Vol. 55. – P. 81-182, 318-189.373.Pinto, L. M. Immunodiagnosis of tuberculosis: state of the art / L. M. Pinto,J. Grenier, S. G. Schumacher // Med. Princ. Pract. – 2012. – № 21. – P. 4-13.374.Poirier, L. A. Methyl group deficiency in hepatocarcinogenesis / L. A.Poirier // Drug Metab. Rev. – 1994. – Vol. 26, № 1–2.
–- P. 185–199.375.Potential role for ESAT6 in dissemination of M. tuberculosis via humanlung epithelial cells / A. G. Kinhikar [et al.] // Mol. Microbiol. – 2010. – Vol. 75,№ 1. – P. 92-106.376.PPE protein (Rv3873) from DNA segment RD1 of Mycobacteriumtuberculosis: strong recognition of both specific T-Celle pitopes and epitopesconserved within the PPE family / L. M.
Okkels [et al.] // Infect. Immunity. –2003. – Vol. 71, № 11. – P. 6116–6123.377.Prasad, S. Unhealthy smokers: scopes for prophylactic intervention andclinical treatment / S. Prasad, M. A. Kaisar, L. Cucullo // BMC Neurosci. – 2017.– Vol. 18, № 1. – P. 70.244378.Predicting the physiological relevance of in vitro cancer preventiveactivities of phytochemicals / L. M. Howells [et al.] // Acta Pharmacol.
Sin. –2007. – Vol. 28, № 9. – P. 1274–1304.379.Probing host pathogen cross-talk by transcriptional profiling of bothMycobacterium tuberculosis and infected human dendritic cells and macrophages/ L. Tailleux [et al.] // PLoS One. – 2008. – Vol. 3. – e1403.380.Progression from latent infection to active disease in dynamic tuberculosistransmission models: a systematic review of the validity of modellingassumptions [Electronic resource] / N.
A. Menzies [et al.] // Lancet Infect. Dis. –2018. – DOI: 10.1016/S1473-3099(18)30134-8.381.Protective CD4 T cells targeting cryptic epitopes of Mycobacteriumtuberculosis resist infection-driven terminal differentiation / J. S. Woodworth [etal.] // J. Immunol. – 2014.
– Vol. 192, № 7. – P. 3247-3258.382.Purification and characterization of a low-molecularmass T-cell antigensecreted by Mycobacterium tuberculosis / A. L. Sorensen [et al.] // Infect Immun.– 1995. – Vol. 63. –P. 1710-1717.383.Quantifying limits on replication, death, and quiescence of Mycobacteriumtuberculosis in mice / M.
M. McDaniel [et al.] // Front. Microbiol. – 2016. – Vol.7. – P. 862.384.Quantitative comparison of active and latent tuberculosis in thecynomolgus macaque model / P. L. Lin [et al.] // Infect. Immunity. – 2009. – Vol.77, № 10. – P. 4631-4642.385.Quesniaux, V. Toll like receptor pathways in the immune responses tomycobacteria / V. Quesniaux, C. Fremond, M.
Jacobs // Microbes Infect. – 2004.– Vol. 6. – P. 946-959.386.Re-annotation of the genome sequence of Mycobacterium tuberculosisH37Rv / J. C. Camus [et al.] // Microbiology. – 2002. – Vol. 148. – P. 2967–2973.245387.Recognition of stage-specific mycobacterial antigens differentiates betweenacute and latent infections with Mycobacterium tuberculosis / A. Demissie [et al.]// Clin. Vaccine Immunol. – 2006.
– Vol. 13, № 2. – P. 179-186.388.Recommendations for investigating contacts of persons with infectioustuberculosis in low- and middle-income countries [Electronic resource] / WorldHealthOrganization.–Geneva:WHO,2012.–URL:http://apps.who.int/iris/bitstream/handle/10665/77741/9789241504492_eng.pdf?sequence=1.389.Regulation of cell wall synthesis and growth / L.
G. Dover [et al.] // Curr.Mol. Med. – 2007. – Vol. 7, № 3. – P. 247–276.390.Regulation of the Mycobacterium tuberculosis PE/PPE genes / M. I.Voskuil [et al.] // Tuberculosis (Edinb). – 2004. – Vol. 84. – P. 256-262.391.Reinforcing the functionality of mononuclear phagocyte system to controltuberculosis / S. Pahari [et al.] // Front. Immunol.
– 2018, – Vol. 9. – P. 193.392.Replication dynamics of Mycobacterium tuberculosis in chronicallyinfected mice / E. J. Muñoz-Elías [et al.] // Infect. Immunity. – 2005. – Vol. 73,№ 1. – P. 546-551.393.Roberts, L. L. Mycobacterium tuberculosis infection of human dendriticcells decrease sintegrin expression, adhesion and migration to chemokines / L.
L.Roberts, C. M. Robinson // Immunology. – 2014. – Vol. 141. – P. 39–51.394.Rohde, K. H. Mycobacterium tuberculosis invasion of macrophages:linking bacterial gene expression to environmental cues / K. H. Rohde, R. B.Abramovitch, D. G. Russell // Cell Host Microbe. – 2007. – № 2. – P. 352-364.395.Role of chemokine ligand 2 in the protective response to early murinepulmonary tuberculosis / A. Kipnis [et al.] // Immunology. – 2003. – Vol. 109, №4. – P. 547-551.396.Role of interferons in the development of diagnostics, vaccines, andtherapy for tuberculosis [Electronic resource] / K.
L. Chin [et al.] // J. Immunol.Res. – 2017. – DOI: 10.1155/2017/5212910.246397.Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection / I.Sugawara [et al.] // Microbiol. Immunol. – 2001. – Vol. 45, № 11. – Р. 743–50. –doi: 10.1111/j.1348-0421.2001.tb01310.398.Roleofmonocytechemoattractantprotein-1(MCP-1)inTh1(mycobacterial) and Th2 (schistosomal) antigen induced granuloma formation:relationship to local inflammation, Th cell expression, and IL-12 production / S.W. Chensue [et al.] // J. Immunol.
– 1996. – Vol. 157, № 10. – P. 4602-4608.399.Role of the major antigen of Mycobacterium tuberculosis in cell wallbiogenesis / J. T. Belisle [et al.] // Science. – 1997. – Vol. 276, № 5317. – P.1420–1422.400.Rosenkrands, I. Assessment of T cell response to novel Mycobacteriumtuberculosis synthetic overlapping peptides mixtures (Rv2659 and Rv2660) andESAT-6 in Egyptian patients / I. Rosenkrands, P.
Andersen, A. R. Abdel-Ghaffar/ Egypt J. Immunol. – 2014. – Vol. 21, № 2. – P. 75-83.401.Rv3133c/dosR is a transcription factor that mediates the hypoxic responseof Mycobacterium tuberculosis / H. D. Park [et al.] // Mol. Microbiol. – 2003. –Vol. 48. – P. 833-843.402.Sada, E. An ELISA for the serodiagnosis of tuberculosis using a 30,000-Danative antigen of Mycobacterium tuberculosis // E. Sada, L. E. Ferguson, T. M.Daniel // Infect.
Dis. – 1990. – Vol. 162. – P. 928–931.403.Sampson, S. L. Mycobacterial PE/PPE proteins at the host-pathogeninterface [Electronic resource] / S. L. Sampson // Clin. Dev. Immunol. – 2011. –DOI: 10.1155/2011/497203.404.Seder, R. A. T-cell quality in memory and protection: implications forvaccine design / R. A.
Seder, P. A. Darrah, M. Roederer // Nat. Rev. Immunol. –2008. – Vol. 8, № 4. – P. 247–258.405.Segal, A. W. How neutrophils kill microbes / A. W. Segal // Annu. Rev.Immunol.– 2005.–Vol.23.10.1146/annurev.immunol.23.021704.115653.–P.197–223.–doi:247406.Seibert, F. B. PPD-S was comprised of approximately 92.1% protein, 5.9%polysaccharides and 1.2% nucleic acid / F. B. Seibert, J. T. Glen // Am. Rev.Tuberc. –1941. – Vol. 44. – P. 9–24.407.Serodiagnostic potential of culture filtrate antigens of Mycobacteriumtuberculosis / K.
M. Samanich [et al.] // Clin. Diagn. Lab. Immunol. – 2000. –Vol. 7. – P. 662–668.408.Sia, J. K. Innate immune defenses in human tuberculosis: an overview ofthe interactions between Mycobacterium tuberculosis and innate immune cells[Electronic resource] / J. K. Sia, M. Georgieva, J. Rengarajan // J. Immunol.Res.– 2015. – DOI: 10.1155/2015/747543.409.Siegrist, C. A. Neonatal and early life vaccinology / C. A. Siegrist //Vaccine. – 2001.
– Vol. 19, № 25-26. – P. 3331–3346.410.Siegrist, C. A. The challenges of vaccine responses in early life: selectedexamples / C. A. Siegrist // J. Comp. Pathol. – 2007. – Vol. 137, suppl. 1. – P. S4–S9.411.Signaling through NOD-2 and TLR-4 bolsters the T cell priming capabilityof dendritic cells by inducing autophagy [Electronic resource] / N.
Khan [et al.] //Sci. Rep. – 2016. – Vol. 6. – P. 19084. – DOI: 10.1038/srep19084.412.Simian immunodeficiency virus-induced changes in T cell cytokineresponses in cynomolgus macaques with latent Mycobacterium tuberculosisinfection are associated with timing of reactivation / J. T. Mattila [et al.] // J.Immunol. – 2011. – Vol. 186, № 6.
– P. 3527–3537.413.Singh, K. P. Genetic and epigenetic changes induced by chronic low doseexposure to arsenic of mouse testicular Leydig cells / K. P. Singh, J. W. Dumond// Int. J. Oncol. – 2007. – Vol. 30, № 1. – P. 253–260.414.Skinner, M. K. Environmental signals and transgenerational epigenetics /M. K. Skinner, C. Guerrero-Bosagna // Epigenomics.
– 2009. – Vol. 1, № 1. – P.111–117.248415.Smith, I. Mycobacterium tuberculosis pathogenesis and moleculardeterminants of virulence / I. Smith // Clin. Microbiol. Rev. – 2003. – Vol.16. –P. 463-496.416.Starke, J. R. Interferon-gamma release assays for diagnosis of tuberculosisinfection and disease in children / J. R. Starke // Pediatrics. – 2014. – Vol. 134, №6.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
